Global Nerve Repair and Regeneration Market 2023-2027

Description

List of Tables

Technavio has been monitoring the nerve repair and regeneration market and it is poised to grow by $4891.9 mn during 2023-2027, accelerating at a CAGR of 11.23% during the forecast period. Our report on the nerve repair and regeneration market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of neurological disorders, increasing government funds for research on neurological diseases, and the expansion of neurology-related research projects.

Technavio's nerve repair and regeneration market is segmented as below:

By Product

Neuromodulation devices
Biomaterials

By Application

Neurorrhaphy
Nerve grafting
Stem cell therapy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the technological advancements for nerve repair and regeneration as one of the prime reasons driving the nerve repair and regeneration market growth during the next few years. Also, improvements in stem cell treatment for nerve repair and regeneration and the increasing number of clinical trials will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the nerve repair and regeneration market covers the following areas:

Nerve repair and regeneration market sizing
Nerve repair and regeneration market forecast
Nerve repair and regeneration market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading nerve repair and regeneration market vendors that include Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, AxoGen Inc., Baxter International Inc., BioWaveGO USA, Boston Scientific Corp., Check Point Surgical Inc., Collagen Matrix Inc., Gimer Medical Co. Ltd., Integra Lifesciences Holdings Corp., KeriMedical SA, LivaNova Plc, Medtronic Plc, NEURONETICS Inc., NeuroPace Inc., NeuroSigma Inc., Polyganics BV, Soterix Medical Inc., Stryker Corp., and Synapse Biomedical Inc. Also, the nerve repair and regeneration market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR74728

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global nerve repair and regeneration market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global nerve repair and regeneration market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Neuromodulation devices - Market size and forecast 2022-2027
Exhibit 34: Chart on Neuromodulation devices - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Neuromodulation devices - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Neuromodulation devices - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Neuromodulation devices - Year-over-year growth 2022-2027 (%)
6.4 Biomaterials - Market size and forecast 2022-2027
Exhibit 38: Chart on Biomaterials - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Biomaterials - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Biomaterials - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Biomaterials - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by Application

7.1 Market segments
Exhibit 43: Chart on Application - Market share 2022-2027 (%)
Exhibit 44: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 45: Chart on Comparison by Application
Exhibit 46: Data Table on Comparison by Application
7.3 Neurorrhaphy - Market size and forecast 2022-2027
Exhibit 47: Chart on Neurorrhaphy - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Neurorrhaphy - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Neurorrhaphy - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Neurorrhaphy - Year-over-year growth 2022-2027 (%)
7.4 Nerve grafting - Market size and forecast 2022-2027
Exhibit 51: Chart on Nerve grafting - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Nerve grafting - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Nerve grafting - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Nerve grafting - Year-over-year growth 2022-2027 (%)
7.5 Stem cell therapy - Market size and forecast 2022-2027
Exhibit 55: Chart on Stem cell therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Stem cell therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Stem cell therapy - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Stem cell therapy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Application
Exhibit 59: Market opportunity by Application ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 India - Market size and forecast 2022-2027
Exhibit 101: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on India - Year-over-year growth 2022-2027 (%)
9.13 Market opportunity By Geographical Landscape
Exhibit 105: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 106: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 108: Overview on factors of disruption
11.4 Industry risks
Exhibit 109: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 110: Vendors covered
12.2 Market positioning of vendors
Exhibit 111: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 112: Abbott Laboratories - Overview
Exhibit 113: Abbott Laboratories - Business segments
Exhibit 114: Abbott Laboratories - Key news
Exhibit 115: Abbott Laboratories - Key offerings
Exhibit 116: Abbott Laboratories - Segment focus
12.4 ALEVA NEUROTHERAPEUTICS SA
Exhibit 117: ALEVA NEUROTHERAPEUTICS SA - Overview
Exhibit 118: ALEVA NEUROTHERAPEUTICS SA - Product / Service
Exhibit 119: ALEVA NEUROTHERAPEUTICS SA - Key offerings
12.5 AxoGen Inc.
Exhibit 120: AxoGen Inc. - Overview
Exhibit 121: AxoGen Inc. - Product / Service
Exhibit 122: AxoGen Inc. - Key offerings
12.6 Baxter International Inc.
Exhibit 123: Baxter International Inc. - Overview
Exhibit 124: Baxter International Inc. - Business segments
Exhibit 125: Baxter International Inc. - Key news
Exhibit 126: Baxter International Inc. - Key offerings
Exhibit 127: Baxter International Inc. - Segment focus
12.7 Boston Scientific Corp.
Exhibit 128: Boston Scientific Corp. - Overview
Exhibit 129: Boston Scientific Corp. - Business segments
Exhibit 130: Boston Scientific Corp. - Key news
Exhibit 131: Boston Scientific Corp. - Key offerings
Exhibit 132: Boston Scientific Corp. - Segment focus
12.8 Collagen Matrix Inc.
Exhibit 133: Collagen Matrix Inc. - Overview
Exhibit 134: Collagen Matrix Inc. - Product / Service
Exhibit 135: Collagen Matrix Inc. - Key offerings
12.9 Integra Lifesciences Holdings Corp.
Exhibit 136: Integra Lifesciences Holdings Corp. - Overview
Exhibit 137: Integra Lifesciences Holdings Corp. - Business segments
Exhibit 138: Integra Lifesciences Holdings Corp. - Key news
Exhibit 139: Integra Lifesciences Holdings Corp. - Key offerings
Exhibit 140: Integra Lifesciences Holdings Corp. - Segment focus
12.10 LivaNova Plc
Exhibit 141: LivaNova Plc - Overview
Exhibit 142: LivaNova Plc - Business segments
Exhibit 143: LivaNova Plc - Key offerings
Exhibit 144: LivaNova Plc - Segment focus
12.11 Medtronic Plc
Exhibit 145: Medtronic Plc - Overview
Exhibit 146: Medtronic Plc - Business segments
Exhibit 147: Medtronic Plc - Key news
Exhibit 148: Medtronic Plc - Key offerings
Exhibit 149: Medtronic Plc - Segment focus
12.12 NEURONETICS Inc.
Exhibit 150: NEURONETICS Inc. - Overview
Exhibit 151: NEURONETICS Inc. - Product / Service
Exhibit 152: NEURONETICS Inc. - Key offerings
12.13 NeuroPace Inc.
Exhibit 153: NeuroPace Inc. - Overview
Exhibit 154: NeuroPace Inc. - Product / Service
Exhibit 155: NeuroPace Inc. - Key offerings
12.14 Polyganics BV
Exhibit 156: Polyganics BV - Overview
Exhibit 157: Polyganics BV - Product / Service
Exhibit 158: Polyganics BV - Key offerings
12.15 Soterix Medical Inc.
Exhibit 159: Soterix Medical Inc. - Overview
Exhibit 160: Soterix Medical Inc. - Product / Service
Exhibit 161: Soterix Medical Inc. - Key offerings
12.16 Stryker Corp.
Exhibit 162: Stryker Corp. - Overview
Exhibit 163: Stryker Corp. - Business segments
Exhibit 164: Stryker Corp. - Key news
Exhibit 165: Stryker Corp. - Key offerings
Exhibit 166: Stryker Corp. - Segment focus
12.17 Synapse Biomedical Inc.
Exhibit 167: Synapse Biomedical Inc. - Overview
Exhibit 168: Synapse Biomedical Inc. - Product / Service
Exhibit 169: Synapse Biomedical Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations